In addition, a study revealed that receptor interacting protein 2 (RIP2) was upregulated in TMZ‐resistant glioma cells in correlation with drug resistance, and the RIP2/NF‐κB/MGMT signalling pathway plays a vital role in the regulation of TMZ resistance [19]. The gene discussed is RIPK2; the disease is central nervous system cancer.